News

Lauterbur struggled for years to find financing for his research, until securing critical funding from both the National ...
Strong real estate inventory and a deep pipeline of talent once again helped the Philadelphia region rank among the nation's ...
By investing in advanced planning and scheduling (APS) solutions, manufacturers can unlock new levels of agility, ...
Employment in the U.S. life sciences sector hit a record high in 2024, and more job growth is expected in 2025.
Here are the members of HiveBio's first cohort for its life sciences accelerator program geared towards underrepresented ...
As the U.S. life sciences real estate sector recovers from a challenging year in 2024, other markets across the globe, ...
Despite a challenging 2024 for Boston’s life sciences market—marked by softening fundamentals and an oversupply of lab ...
The rise of life science startups is revolutionizing healthcare, leveraging biotechnology to address critical health ...
New York State is a top recipient of NIH funding and is expected to lose about $880 million.
CBD Life Sciences (CBDL) saw a 500% increase in online sales this past quarter, as it sees rapidly expanding global wellness economy.
As previously reported, Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Wave stands out ...
The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...